Tarsus Pharmaceuticals, Inc. (TARS) stock
TARSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/309% above fair value
$80.28+3.39 (+4.41%)
Close on Nov 13, 2026Market cap $3.52BP/E –Yield 0.00%
Tarsus Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Tarsus Pharmaceuticals's operating margin for the twelve months ending Jun 30, 2026 was -8.0%. For fiscal 2025 it was -15.7%, against -65.9% the year before. The highest annual figure on record is -15.7% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -15.7% | +50.2 |
| FY2024 | Dec 31, 2024 | -65.9% | +754.6 |
| FY2023 | Dec 31, 2023 | -820.5% | −577.6 |
| FY2022 | Dec 31, 2022 | -242.9% | −221.6 |
| FY2021 | Dec 31, 2021 | -21.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -11.4% | +10.2 |
| Q1 FY2026 | Mar 31, 2026 | -3.8% | +29.8 |
| Q4 FY2025 | Dec 31, 2025 | -5.3% | +31.5 |
| Q3 FY2025 | Sep 30, 2025 | -12.2% | +40.1 |
| Q2 FY2025 | Jun 30, 2025 | -21.6% | +60.0 |
| Q1 FY2025 | Mar 31, 2025 | -33.5% | +102.9 |
| Q4 FY2024 | Dec 31, 2024 | -36.8% | +303.2 |
| Q3 FY2024 | Sep 30, 2024 | -52.3% | +2135.6 |
| Q2 FY2024 | Jun 30, 2024 | -81.6% | +916.5 |
| Q1 FY2024 | Mar 31, 2024 | -136.5% | +14.1 |
| Q4 FY2023 | Dec 31, 2023 | -339.9% | −305.7 |
| Q3 FY2023 | Sep 30, 2023 | -2187.9% | +1433.8 |
| Q1 FY2023 | Mar 31, 2023 | -998.1% | +3276.5 |
| Q4 FY2022 | Dec 31, 2022 | -150.6% | +1115.9 |
| Q2 FY2022 | Jun 30, 2022 | -34.2% | −67.3 |
| Q1 FY2022 | Mar 31, 2022 | -3621.7% | −3653.8 |
| Q4 FY2021 | Dec 31, 2021 | -4274.6% | – |
| Q3 FY2021 | Sep 30, 2021 | -1266.5% | – |
| Q2 FY2021 | Jun 30, 2021 | 33.1% | – |
| Q1 FY2021 | Mar 31, 2021 | 32.0% | – |
See a number that looks wrong?